Literature DB >> 16565567

Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model.

Zhan-Qiang Shao1, Kentaro Takaji, Yukihiro Katayama, Ryuji Kunitomo, Hisashi Sakaguchi, Zhong-Fang Lai, Michio Kawasuji.   

Abstract

BACKGROUND: Basic fibroblast growth factor (bFGF) stimulates neoangiogenesis. Incorporation into biodegradable gelatin hydrogels provides the sustained release of bFGF. The effects of intramyocardial injections of slow-release bFGF on neoangiogenesis in a rat model of infarction were investigated. METHODS AND
RESULTS: Myocardial infarction was induced in rats using coronary artery ligation. A total of 124 rats received an intramyocardial injection of 20 microg of bFGF, the same amount of bFGF incorporated into gelatin hydrogel (bFGF + gel), gelatin hydrogel (gel) or saline. Ventricular function was evaluated by echocardiography 2 or 4 weeks later. Morphometric and histological analyses were used to evaluate infarct size, vascular density and myocardial apoptosis. Capillary density in the infarct border zone was higher in the bFGF and bFGF + gel groups than in the saline and gel groups at 4 weeks (p<0.001). Arteriolar density was higher in the bFGF + gel group than in the other 3 groups (p<0.05). The bFGF and bFGF + gel groups contained fewer apoptotic cardiomyocytes in the border zone than the saline and gel groups (p<0.01). The bFGF+gel group had thicker (p<0.05) and less expanded infarcts (p<0.01) compared with the saline group at 4 weeks.
CONCLUSIONS: Incorporation of bFGF in gelatin hydrogels enhanced the effects of bFGF on arteriogenesis, ventricular remodeling and cardiac function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565567     DOI: 10.1253/circj.70.471

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  14 in total

Review 1.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

2.  Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium.

Authors:  Jessica C Garbern; Elina Minami; Patrick S Stayton; Charles E Murry
Journal:  Biomaterials       Date:  2010-12-24       Impact factor: 12.479

3.  Effect of bone marrow-derived extracellular matrix on cardiac function after ischemic injury.

Authors:  Swathi Ravi; Jeffrey M Caves; Adam W Martinez; Jiantao Xiao; Jing Wen; Carolyn A Haller; Michael E Davis; Elliot L Chaikof
Journal:  Biomaterials       Date:  2012-07-21       Impact factor: 12.479

4.  Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model.

Authors:  Shao-ping Nie; Xiao Wang; Shi-bin Qiao; Qiu-tang Zeng; Ju-quan Jiang; Xiao-qing Liu; Xiang-ming Zhu; Guo-xiang Cao; Chang-sheng Ma
Journal:  J Zhejiang Univ Sci B       Date:  2010-12       Impact factor: 3.066

Review 5.  Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges.

Authors:  Devin M Nelson; Zuwei Ma; Kazuro L Fujimoto; Ryotaro Hashizume; William R Wagner
Journal:  Acta Biomater       Date:  2010-07-07       Impact factor: 8.947

6.  rAAV-mediated angiogenin gene transfer induces angiogenesis and modifies left ventricular remodeling in rats with myocardial infarction.

Authors:  Xiao-Yan Zhao; Shen-Jiang Hu; Jiang Li; Yun Mou; Chi-Fung Chan; Juan Jin; Jian Sun; Zhao-Hui Zhu
Journal:  J Mol Med (Berl)       Date:  2006-09-06       Impact factor: 4.599

7.  Extended and sequential delivery of protein from injectable thermoresponsive hydrogels.

Authors:  Devin M Nelson; Zuwei Ma; Cory E Leeson; William R Wagner
Journal:  J Biomed Mater Res A       Date:  2012-01-11       Impact factor: 4.396

Review 8.  The current status of engineering myocardial tissue.

Authors:  Runqian Sui; Xiaobo Liao; Xinmin Zhou; Qi Tan
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

9.  Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathy.

Authors:  Devin M Nelson; Ryotaro Hashizume; Tomo Yoshizumi; Anna K Blakney; Zuwei Ma; William R Wagner
Journal:  Biomacromolecules       Date:  2014-01-02       Impact factor: 6.988

10.  Spatiotemporal delivery of basic fibroblast growth factor to directly and simultaneously attenuate cardiac fibrosis and promote cardiac tissue vascularization following myocardial infarction.

Authors:  Zhaobo Fan; Zhaobin Xu; Hong Niu; Yang Sui; Haichang Li; Jianjie Ma; Jianjun Guan
Journal:  J Control Release       Date:  2019-09-12       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.